Click for best price
Temporal Arteritis Market Size, Share 2024
The global Temporal Arteritis market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Temporal Arteritis include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd and Pfizer Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.
This report aims to provide a comprehensive presentation of the global market for Temporal Arteritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Temporal Arteritis. This report contains market size and forecasts of Temporal Arteritis in global, including the following market information:
Global Temporal Arteritis Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Temporal Arteritis Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Temporal Arteritis companies in 2023 (%)
We surveyed the Temporal Arteritis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Temporal Arteritis Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Temporal Arteritis Market Segment Percentages, by Type, 2023 (%)
Oral
Parenteral
Global Temporal Arteritis Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Temporal Arteritis Market Segment Percentages, by Application, 2023 (%)
Hospital
Home Care
Other
Global Temporal Arteritis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Temporal Arteritis Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Temporal Arteritis revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Temporal Arteritis revenues share in global market, 2023 (%)
Key companies Temporal Arteritis sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Temporal Arteritis sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann -La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Amorphex Therapeutics Holdings, Inc
Bausch Health Companies Inc
Regeneron Pharmaceuticals Inc
Astellas Pharma Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Temporal Arteritis, market overview.
Chapter 2: Global Temporal Arteritis market size in revenue and volume.
Chapter 3: Detailed analysis of Temporal Arteritis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Temporal Arteritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Temporal Arteritis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Temporal Arteritis Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Temporal Arteritis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Temporal Arteritis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Temporal Arteritis Overall Market Size
2.1 Global Temporal Arteritis Market Size: 2023 VS 2030
2.2 Global Temporal Arteritis Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Temporal Arteritis Sales: 2019-2030
3 Company Landscape
3.1 Top Temporal Arteritis Players in Global Market
3.2 Top Global Temporal Arteritis Companies Ranked by Revenue
3.3 Global Temporal Arteritis Revenue by Companies
3.4 Global Temporal Arteritis Sales by Companies
3.5 Global Temporal Arteritis Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Temporal Arteritis Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Temporal Arteritis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Temporal Arteritis Players in Global Market
3.8.1 List of Global Tier 1 Temporal Arteritis Companies
3.8.2 List of Global Tier 2 and Tier 3 Temporal Arteritis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Temporal Arteritis Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Temporal Arteritis Revenue & Forecasts
4.2.1 By Type - Global Temporal Arteritis Revenue, 2019-2024
4.2.2 By Type - Global Temporal Arteritis Revenue, 2025-2030
4.2.3 By Type - Global Temporal Arteritis Revenue Market Share, 2019-2030
4.3 By Type - Global Temporal Arteritis Sales & Forecasts
4.3.1 By Type - Global Temporal Arteritis Sales, 2019-2024
4.3.2 By Type - Global Temporal Arteritis Sales, 2025-2030
4.3.3 By Type - Global Temporal Arteritis Sales Market Share, 2019-2030
4.4 By Type - Global Temporal Arteritis Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Temporal Arteritis Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Home Care
5.1.4 Other
5.2 By Application - Global Temporal Arteritis Revenue & Forecasts
5.2.1 By Application - Global Temporal Arteritis Revenue, 2019-2024
5.2.2 By Application - Global Temporal Arteritis Revenue, 2025-2030
5.2.3 By Application - Global Temporal Arteritis Revenue Market Share, 2019-2030
5.3 By Application - Global Temporal Arteritis Sales & Forecasts
5.3.1 By Application - Global Temporal Arteritis Sales, 2019-2024
5.3.2 By Application - Global Temporal Arteritis Sales, 2025-2030
5.3.3 By Application - Global Temporal Arteritis Sales Market Share, 2019-2030
5.4 By Application - Global Temporal Arteritis Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Temporal Arteritis Market Size, 2023 & 2030
6.2 By Region - Global Temporal Arteritis Revenue & Forecasts
6.2.1 By Region - Global Temporal Arteritis Revenue, 2019-2024
6.2.2 By Region - Global Temporal Arteritis Revenue, 2025-2030
6.2.3 By Region - Global Temporal Arteritis Revenue Market Share, 2019-2030
6.3 By Region - Global Temporal Arteritis Sales & Forecasts
6.3.1 By Region - Global Temporal Arteritis Sales, 2019-2024
6.3.2 By Region - Global Temporal Arteritis Sales, 2025-2030
6.3.3 By Region - Global Temporal Arteritis Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Temporal Arteritis Revenue, 2019-2030
6.4.2 By Country - North America Temporal Arteritis Sales, 2019-2030
6.4.3 US Temporal Arteritis Market Size, 2019-2030
6.4.4 Canada Temporal Arteritis Market Size, 2019-2030
6.4.5 Mexico Temporal Arteritis Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Temporal Arteritis Revenue, 2019-2030
6.5.2 By Country - Europe Temporal Arteritis Sales, 2019-2030
6.5.3 Germany Temporal Arteritis Market Size, 2019-2030
6.5.4 France Temporal Arteritis Market Size, 2019-2030
6.5.5 U.K. Temporal Arteritis Market Size, 2019-2030
6.5.6 Italy Temporal Arteritis Market Size, 2019-2030
6.5.7 Russia Temporal Arteritis Market Size, 2019-2030
6.5.8 Nordic Countries Temporal Arteritis Market Size, 2019-2030
6.5.9 Benelux Temporal Arteritis Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Temporal Arteritis Revenue, 2019-2030
6.6.2 By Region - Asia Temporal Arteritis Sales, 2019-2030
6.6.3 China Temporal Arteritis Market Size, 2019-2030
6.6.4 Japan Temporal Arteritis Market Size, 2019-2030
6.6.5 South Korea Temporal Arteritis Market Size, 2019-2030
6.6.6 Southeast Asia Temporal Arteritis Market Size, 2019-2030
6.6.7 India Temporal Arteritis Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Temporal Arteritis Revenue, 2019-2030
6.7.2 By Country - South America Temporal Arteritis Sales, 2019-2030
6.7.3 Brazil Temporal Arteritis Market Size, 2019-2030
6.7.4 Argentina Temporal Arteritis Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Temporal Arteritis Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Temporal Arteritis Sales, 2019-2030
6.8.3 Turkey Temporal Arteritis Market Size, 2019-2030
6.8.4 Israel Temporal Arteritis Market Size, 2019-2030
6.8.5 Saudi Arabia Temporal Arteritis Market Size, 2019-2030
6.8.6 UAE Temporal Arteritis Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Temporal Arteritis Major Product Offerings
7.1.4 Novartis AG Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Endo International Inc
7.2.1 Endo International Inc Company Summary
7.2.2 Endo International Inc Business Overview
7.2.3 Endo International Inc Temporal Arteritis Major Product Offerings
7.2.4 Endo International Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.2.5 Endo International Inc Key News & Latest Developments
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Company Summary
7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.3.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.4 Glenmark Pharmaceuticals Ltd
7.4.1 Glenmark Pharmaceuticals Ltd Company Summary
7.4.2 Glenmark Pharmaceuticals Ltd Business Overview
7.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Major Product Offerings
7.4.4 Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.4.5 Glenmark Pharmaceuticals Ltd Key News & Latest Developments
7.5 Cipla Inc
7.5.1 Cipla Inc Company Summary
7.5.2 Cipla Inc Business Overview
7.5.3 Cipla Inc Temporal Arteritis Major Product Offerings
7.5.4 Cipla Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.5.5 Cipla Inc Key News & Latest Developments
7.6 Dr Reddy's Laboratories Ltd
7.6.1 Dr Reddy's Laboratories Ltd Company Summary
7.6.2 Dr Reddy's Laboratories Ltd Business Overview
7.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Major Product Offerings
7.6.4 Dr Reddy's Laboratories Ltd Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.6.5 Dr Reddy's Laboratories Ltd Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Temporal Arteritis Major Product Offerings
7.7.4 Abbott Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.7.5 Abbott Key News & Latest Developments
7.8 F. Hoffmann -La Roche Ltd
7.8.1 F. Hoffmann -La Roche Ltd Company Summary
7.8.2 F. Hoffmann -La Roche Ltd Business Overview
7.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Major Product Offerings
7.8.4 F. Hoffmann -La Roche Ltd Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.8.5 F. Hoffmann -La Roche Ltd Key News & Latest Developments
7.9 Pfizer Inc
7.9.1 Pfizer Inc Company Summary
7.9.2 Pfizer Inc Business Overview
7.9.3 Pfizer Inc Temporal Arteritis Major Product Offerings
7.9.4 Pfizer Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.9.5 Pfizer Inc Key News & Latest Developments
7.10 Zydus Group
7.10.1 Zydus Group Company Summary
7.10.2 Zydus Group Business Overview
7.10.3 Zydus Group Temporal Arteritis Major Product Offerings
7.10.4 Zydus Group Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.10.5 Zydus Group Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin Temporal Arteritis Business Overview
7.11.3 Lupin Temporal Arteritis Major Product Offerings
7.11.4 Lupin Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.11.5 Lupin Key News & Latest Developments
7.12 Amorphex Therapeutics Holdings, Inc
7.12.1 Amorphex Therapeutics Holdings, Inc Company Summary
7.12.2 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Business Overview
7.12.3 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Major Product Offerings
7.12.4 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.12.5 Amorphex Therapeutics Holdings, Inc Key News & Latest Developments
7.13 Bausch Health Companies Inc
7.13.1 Bausch Health Companies Inc Company Summary
7.13.2 Bausch Health Companies Inc Temporal Arteritis Business Overview
7.13.3 Bausch Health Companies Inc Temporal Arteritis Major Product Offerings
7.13.4 Bausch Health Companies Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.13.5 Bausch Health Companies Inc Key News & Latest Developments
7.14 Regeneron Pharmaceuticals Inc
7.14.1 Regeneron Pharmaceuticals Inc Company Summary
7.14.2 Regeneron Pharmaceuticals Inc Business Overview
7.14.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Major Product Offerings
7.14.4 Regeneron Pharmaceuticals Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.14.5 Regeneron Pharmaceuticals Inc Key News & Latest Developments
7.15 Astellas Pharma Inc
7.15.1 Astellas Pharma Inc Company Summary
7.15.2 Astellas Pharma Inc Business Overview
7.15.3 Astellas Pharma Inc Temporal Arteritis Major Product Offerings
7.15.4 Astellas Pharma Inc Temporal Arteritis Sales and Revenue in Global (2019-2024)
7.15.5 Astellas Pharma Inc Key News & Latest Developments
8 Global Temporal Arteritis Production Capacity, Analysis
8.1 Global Temporal Arteritis Production Capacity, 2019-2030
8.2 Temporal Arteritis Production Capacity of Key Manufacturers in Global Market
8.3 Global Temporal Arteritis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Temporal Arteritis Supply Chain Analysis
10.1 Temporal Arteritis Industry Value Chain
10.2 Temporal Arteritis Upstream Market
10.3 Temporal Arteritis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Temporal Arteritis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Temporal Arteritis in Global Market
Table 2. Top Temporal Arteritis Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Temporal Arteritis Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Temporal Arteritis Revenue Share by Companies, 2019-2024
Table 5. Global Temporal Arteritis Sales by Companies, (K Units), 2019-2024
Table 6. Global Temporal Arteritis Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Temporal Arteritis Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Temporal Arteritis Product Type
Table 9. List of Global Tier 1 Temporal Arteritis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Temporal Arteritis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Temporal Arteritis Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Temporal Arteritis Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Temporal Arteritis Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Temporal Arteritis Sales (K Units), 2019-2024
Table 15. By Type - Global Temporal Arteritis Sales (K Units), 2025-2030
Table 16. By Application ? Global Temporal Arteritis Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Temporal Arteritis Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Temporal Arteritis Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Temporal Arteritis Sales (K Units), 2019-2024
Table 20. By Application - Global Temporal Arteritis Sales (K Units), 2025-2030
Table 21. By Region ? Global Temporal Arteritis Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Temporal Arteritis Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Temporal Arteritis Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Temporal Arteritis Sales (K Units), 2019-2024
Table 25. By Region - Global Temporal Arteritis Sales (K Units), 2025-2030
Table 26. By Country - North America Temporal Arteritis Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Temporal Arteritis Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Temporal Arteritis Sales, (K Units), 2019-2024
Table 29. By Country - North America Temporal Arteritis Sales, (K Units), 2025-2030
Table 30. By Country - Europe Temporal Arteritis Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Temporal Arteritis Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Temporal Arteritis Sales, (K Units), 2019-2024
Table 33. By Country - Europe Temporal Arteritis Sales, (K Units), 2025-2030
Table 34. By Region - Asia Temporal Arteritis Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Temporal Arteritis Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Temporal Arteritis Sales, (K Units), 2019-2024
Table 37. By Region - Asia Temporal Arteritis Sales, (K Units), 2025-2030
Table 38. By Country - South America Temporal Arteritis Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Temporal Arteritis Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Temporal Arteritis Sales, (K Units), 2019-2024
Table 41. By Country - South America Temporal Arteritis Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Temporal Arteritis Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Temporal Arteritis Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Temporal Arteritis Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Temporal Arteritis Sales, (K Units), 2025-2030
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Temporal Arteritis Product Offerings
Table 48. Novartis AG Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Endo International Inc Company Summary
Table 51. Endo International Inc Temporal Arteritis Product Offerings
Table 52. Endo International Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Endo International Inc Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Glenmark Pharmaceuticals Ltd Company Summary
Table 59. Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Offerings
Table 60. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Glenmark Pharmaceuticals Ltd Key News & Latest Developments
Table 62. Cipla Inc Company Summary
Table 63. Cipla Inc Temporal Arteritis Product Offerings
Table 64. Cipla Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Cipla Inc Key News & Latest Developments
Table 66. Dr Reddy's Laboratories Ltd Company Summary
Table 67. Dr Reddy's Laboratories Ltd Temporal Arteritis Product Offerings
Table 68. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Dr Reddy's Laboratories Ltd Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Temporal Arteritis Product Offerings
Table 72. Abbott Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Abbott Key News & Latest Developments
Table 74. F. Hoffmann -La Roche Ltd Company Summary
Table 75. F. Hoffmann -La Roche Ltd Temporal Arteritis Product Offerings
Table 76. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. F. Hoffmann -La Roche Ltd Key News & Latest Developments
Table 78. Pfizer Inc Company Summary
Table 79. Pfizer Inc Temporal Arteritis Product Offerings
Table 80. Pfizer Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Pfizer Inc Key News & Latest Developments
Table 82. Zydus Group Company Summary
Table 83. Zydus Group Temporal Arteritis Product Offerings
Table 84. Zydus Group Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Zydus Group Key News & Latest Developments
Table 86. Lupin Company Summary
Table 87. Lupin Temporal Arteritis Product Offerings
Table 88. Lupin Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Lupin Key News & Latest Developments
Table 90. Amorphex Therapeutics Holdings, Inc Company Summary
Table 91. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Offerings
Table 92. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Amorphex Therapeutics Holdings, Inc Key News & Latest Developments
Table 94. Bausch Health Companies Inc Company Summary
Table 95. Bausch Health Companies Inc Temporal Arteritis Product Offerings
Table 96. Bausch Health Companies Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Bausch Health Companies Inc Key News & Latest Developments
Table 98. Regeneron Pharmaceuticals Inc Company Summary
Table 99. Regeneron Pharmaceuticals Inc Temporal Arteritis Product Offerings
Table 100. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Regeneron Pharmaceuticals Inc Key News & Latest Developments
Table 102. Astellas Pharma Inc Company Summary
Table 103. Astellas Pharma Inc Temporal Arteritis Product Offerings
Table 104. Astellas Pharma Inc Temporal Arteritis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Astellas Pharma Inc Key News & Latest Developments
Table 106. Temporal Arteritis Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Temporal Arteritis Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Temporal Arteritis Production by Region, 2019-2024 (K Units)
Table 109. Global Temporal Arteritis Production by Region, 2025-2030 (K Units)
Table 110. Temporal Arteritis Market Opportunities & Trends in Global Market
Table 111. Temporal Arteritis Market Drivers in Global Market
Table 112. Temporal Arteritis Market Restraints in Global Market
Table 113. Temporal Arteritis Raw Materials
Table 114. Temporal Arteritis Raw Materials Suppliers in Global Market
Table 115. Typical Temporal Arteritis Downstream
Table 116. Temporal Arteritis Downstream Clients in Global Market
Table 117. Temporal Arteritis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Temporal Arteritis Segment by Type in 2023
Figure 2. Temporal Arteritis Segment by Application in 2023
Figure 3. Global Temporal Arteritis Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Temporal Arteritis Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Temporal Arteritis Revenue, 2019-2030 (US$, Mn)
Figure 7. Temporal Arteritis Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Temporal Arteritis Revenue in 2023
Figure 9. By Type - Global Temporal Arteritis Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Temporal Arteritis Revenue Market Share, 2019-2030
Figure 11. By Type - Global Temporal Arteritis Sales Market Share, 2019-2030
Figure 12. By Type - Global Temporal Arteritis Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Temporal Arteritis Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Temporal Arteritis Revenue Market Share, 2019-2030
Figure 15. By Application - Global Temporal Arteritis Sales Market Share, 2019-2030
Figure 16. By Application - Global Temporal Arteritis Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Temporal Arteritis Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Temporal Arteritis Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Temporal Arteritis Revenue Market Share, 2019-2030
Figure 20. By Region - Global Temporal Arteritis Sales Market Share, 2019-2030
Figure 21. By Country - North America Temporal Arteritis Revenue Market Share, 2019-2030
Figure 22. By Country - North America Temporal Arteritis Sales Market Share, 2019-2030
Figure 23. US Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Temporal Arteritis Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Temporal Arteritis Sales Market Share, 2019-2030
Figure 28. Germany Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 29. France Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Temporal Arteritis Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Temporal Arteritis Sales Market Share, 2019-2030
Figure 37. China Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 41. India Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Temporal Arteritis Revenue Market Share, 2019-2030
Figure 43. By Country - South America Temporal Arteritis Sales Market Share, 2019-2030
Figure 44. Brazil Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Temporal Arteritis Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Temporal Arteritis Sales Market Share, 2019-2030
Figure 48. Turkey Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Temporal Arteritis Revenue, (US$, Mn), 2019-2030
Figure 52. Global Temporal Arteritis Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Temporal Arteritis by Region, 2023 VS 2030
Figure 54. Temporal Arteritis Industry Value Chain
Figure 55. Marketing Channels
